Particle.news

Download on the App Store

Membrane Lipid Drives Biased Signaling in 5-HT1A Serotonin Receptor

Researchers at Mount Sinai plan to validate their molecular findings in complex models before designing targeted antidepressant candidates.

Image
Using innovative lab techniques, the research team discovered that the 5-HT1A receptor is inherently wired to favor certain cellular signaling pathways over others—regardless of the drug used to target it. Credit: Neuroscience News

Overview

  • Cryo-electron microscopy and in vitro assays revealed that the 5-HT1A receptor inherently favors specific G protein pathways regardless of ligand.
  • The antipsychotic asenapine (Saphris) was shown to selectively modulate the strength of one signaling route due to its partial agonist profile.
  • A phospholipid molecule within the cell membrane was identified as a crucial co-factor that steers receptor conformation and activity.
  • Structural maps pinpoint both orthosteric and allosteric determinants that can guide the design of drugs targeting distinct signaling cascades.
  • Next steps include testing these insights in advanced biological models and developing candidate compounds for faster and more precise mental health therapies.